| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/11/2007 | EP1805154A2 Pharmaceutical compositions |
| 07/11/2007 | EP1805148A2 Crystalline rosuvastatin intermediate |
| 07/11/2007 | EP1805136A1 Substituted phenylalkanoic acids |
| 07/11/2007 | EP1804799A2 Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| 07/11/2007 | EP1804797A1 Use of a pyridine compound for the preparation of a medicament for the treatment of skin lesions |
| 07/11/2007 | EP1804795A2 Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease |
| 07/11/2007 | EP1804792A1 Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coa-desaturase (scd) |
| 07/11/2007 | EP1804791A1 Tetrahydro pyridinyl pyrazole cannabinoid modulators |
| 07/11/2007 | EP1804769A1 Pharmaceutical compositions comprising fenofibrate and atorvastatin |
| 07/11/2007 | EP1804768A1 Pharmaceutical compositions comprising fenofibrate and atorvastatin |
| 07/11/2007 | EP1686983B1 Use of pentadienoic acid derivates for treatement of hyperuricemia |
| 07/11/2007 | EP1622899B1 Pioglitazone sulfate, pharmaceutical compositions and their use |
| 07/11/2007 | EP1204414B1 Use of morphinan derivates as medicines |
| 07/11/2007 | EP1140907B1 Triazole compounds with dopamine-d3-receptor affinity |
| 07/11/2007 | EP1135128B1 Novel method of treatment |
| 07/11/2007 | EP1028945B1 Substituted pyridine compounds as anti-inflammatory agents |
| 07/11/2007 | EP0998291B1 Treatment of diabetes with thiazolidinedione and sulphonylurea |
| 07/11/2007 | CN1997655A Pyridyl-substituted porphyrin compounds and methods of use thereof |
| 07/11/2007 | CN1997645A Immunomodulating oxopyrrazolocinnolines as CD80 inhibitors |
| 07/11/2007 | CN1997638A 1,1'-(1,2-ethynediyl)bis-benzene derivatives as PTP1-B inhibitors |
| 07/11/2007 | CN1997619A Phenyl derivatives comprising an acetylene group |
| 07/11/2007 | CN1997386A Methods of treating type I diabetes by blocking VEGF-mediated activity |
| 07/11/2007 | CN1997379A Use of an extract of pueraria tuberosa for the treatment of diabetes type 2 |
| 07/11/2007 | CN1997371A Nicotinamide derivatives and their use as therapeutic agents |
| 07/11/2007 | CN1997370A Medicaments containing n-sulfamoyl-n'-arylpiperazines for the prophylaxis or treatment of obesity and related conditions |
| 07/11/2007 | CN1995039A Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 07/11/2007 | CN1995011A Levo- carnitine calcium fumarate and its preparation method and use thereof |
| 07/11/2007 | CN1994403A Pharmaceutical composition for promoting blood circulation and preparation method thereof |
| 07/11/2007 | CN1994396A Health food for assistant treatment of diabetes and preparation method thereof |
| 07/11/2007 | CN1994382A Diet composition combined by blueberry, levo-carnitine, spirulina and lotus leaf |
| 07/11/2007 | CN1994328A Use of Chinese softed turtle egg in preparation of medicine or food for relieving diabetic symptoms and lowering blood sugar |
| 07/11/2007 | CN1994296A Pharmaceutical composition containing simvastatin |
| 07/11/2007 | CN1994146A Chicory diet tea |
| 07/11/2007 | CN1994140A Paste with fleece-flower root and sesame for reducing fat, protecting liver and preventing against osteoprosis |
| 07/11/2007 | CN1994130A A fat-reducing food additive and application thereof |
| 07/11/2007 | CN1994123A Health biscuit series containing astragalus root for diabetic patients and preparation process thereof |
| 07/11/2007 | CN1994110A Health fruit jelly containing snow lotus pulp and preparation process thereof |
| 07/11/2007 | CN1994104A Constipation-relieving tea with snow lotus fruit, cassia seed and arctium fruit and preparation process thereof |
| 07/11/2007 | CN1994103A A Chinese medicine compound health tea |
| 07/11/2007 | CN1994093A Method for producing nutrition reinforced noodle by using spray sandwich technique |
| 07/11/2007 | CN1325651C High-efficiency expression and application of human recombinant interferon B |
| 07/11/2007 | CN1325650C Delivery system for porcine somatotropin |
| 07/11/2007 | CN1325509C Extract of american ginseng fruit saponin, extracting and refining method and medicinal use thereof |
| 07/11/2007 | CN1325498C Novel crystalline compound |
| 07/11/2007 | CN1325488C Heterocyclic derivatives |
| 07/11/2007 | CN1325480C Novel phenylalanine derivatives |
| 07/11/2007 | CN1325462C Novel substituted arylhexadienoic acids and esters thereof which can be used for the treatment and prevention of diabetes, dyslipidaemia and atherosclerosis, pharmaceutical compositions comprising the |
| 07/11/2007 | CN1325089C Chinese patent medicine on health food composition and its use |
| 07/11/2007 | CN1325088C Oral administration liquor for reducing blood fat |
| 07/11/2007 | CN1325087C Chinese medicine preparation for sobering up and liver protection |
| 07/11/2007 | CN1325078C Production process for extracting Chinese-date essence from chinese date |
| 07/11/2007 | CN1325053C Controlled-release drug composition |
| 07/11/2007 | CN1325050C Pharmaceutical composition comprising a lipase inhibitor and glucomannan |
| 07/11/2007 | CN1325049C Composition containing epigallocatechin gallate |
| 07/10/2007 | US7241923 Phenylalkyloxy-phenyl derivatives |
| 07/10/2007 | US7241900 Synthesis of indole thiazole compounds as ligands for the Ah receptor |
| 07/10/2007 | US7241861 High density lipoprotein-reactive peptides |
| 07/10/2007 | US7241793 For therapy of cardiovascular diseases |
| 07/10/2007 | US7241791 Substituted 4-(indazol-3-yl)phenols |
| 07/10/2007 | US7241789 Substituted indoles and their use as integrin antagonists |
| 07/10/2007 | US7241788 Cannabinoid receptor ligands and uses thereof |
| 07/10/2007 | US7241785 Five-membered heterocyclic alkanoic acid derivative |
| 07/10/2007 | US7241782 Modifications are prepared by subjecting an alkaline solution of torasemide to a rapid acidification with inorganic or organic acids at 0 to 35 degrees C. |
| 07/10/2007 | US7241777 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors |
| 07/10/2007 | US7241772 3-[3-(Pyrrolylphenoxy-2-hydroxypropyl)aminoalkyl]imidazo[1,5-a]pyridine derivatives, especially HCl salts; treating obesity |
| 07/10/2007 | US7241765 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 07/10/2007 | US7241762 Administering racemic reboxetine or a salt thereof for inhibition of norepinephrine reuptake |
| 07/10/2007 | US7241758 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases |
| 07/10/2007 | US7241756 Containing 5-[4-[2[(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione or a salt for treating non-insulin dependent diabetes with improved blood glucose regulation without introducing unacceptable side-effects |
| 07/10/2007 | US7241738 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/10/2007 | US7241733 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses |
| 07/10/2007 | US7241619 Identification of genes encoding enzymes (Thraustochytrium aureum Delta 5-desaturase, Saprolegnia diclina Delta 5-desaturase, Saprolegnia diclina Delta 6-desaturase)involved in synthesis of polyunsaturated fatty acids |
| 07/10/2007 | CA2441461C Topical formulations for the transdermal delivery of niacin and methods of treating hyperlipidemia |
| 07/10/2007 | CA2421910C Xanthine phosphodiesterase v inhibitors |
| 07/10/2007 | CA2396814C Novel 1,3-dihydro-2h-indol-2-one derivatives, preparation method and pharmaceutical compositions containing them |
| 07/10/2007 | CA2378628C New indenoindolone derivatives, the process for preparing them and the pharmaceutical compounds that contain them |
| 07/10/2007 | CA2283564C Pharmaceutical compositions having appetite suppressant activity |
| 07/05/2007 | WO2007076387A1 Phytosterols for use in reducing c-reactive protein levels |
| 07/05/2007 | WO2007075847A2 Glucokinase activators |
| 07/05/2007 | WO2007075833A2 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity |
| 07/05/2007 | WO2007075702A2 Treatment of nonalcoholic fatty liver disease using cholesterol lowering agents and h3 receptor antagonist/inverse agonist |
| 07/05/2007 | WO2007075555A2 Combination of an h3 antagonist/inverse agonist and an appetite suppressant |
| 07/05/2007 | WO2007075534A2 Polymer conjugates of glp-1 |
| 07/05/2007 | WO2007075142A1 Long term weight maintenance |
| 07/05/2007 | WO2007074916A1 3,4-dihydrobenzoxazine compound and inhibitor of vanilloid receptor type 1 (vr1) activity |
| 07/05/2007 | WO2007074884A1 Therapeutic agent for diabetes |
| 07/05/2007 | WO2007074859A1 Anti-c-mannosylated peptide antibody and use thereof |
| 07/05/2007 | WO2007074753A1 Pharmaceutical comprising substituted urea derivative |
| 07/05/2007 | WO2007073935A1 Heterocyclic compounds |
| 07/05/2007 | WO2007073934A1 Pyridinyl amine derivatives as inhibitors of cholesteryl ester transfer protein (cetp) |
| 07/05/2007 | WO2007056281A3 Multivalent indole compounds and use thereof as phospholipase-a2 inhibitors |
| 07/05/2007 | WO2007056184A3 Azaindole compounds and use thereof as phospholipase-a2 inhibitors |
| 07/05/2007 | WO2007053765A3 Substituted cycloalkylpyrrolones as allosteric modulators of glucokinase |
| 07/05/2007 | WO2007047880A3 Compositions for lowering serum cholesterol and/or triglycerides |
| 07/05/2007 | WO2007038138A3 Amido compounds and their use as pharmaceuticals |
| 07/05/2007 | WO2007023495A3 Method for production of single- and multi-layer microcapsules |
| 07/05/2007 | WO2007018314A3 Therapeutic agent for diabetes |
| 07/05/2007 | US20070157326 Ee3-protein family and corresponding dna sequence |
| 07/05/2007 | US20070155970 Process for the manufacture of hmg-coa reductase inhibitory mevalonic acid derivatives |
| 07/05/2007 | US20070155950 Alkylated poly(allylamine) polymers and methods of use |